
    
      The study will compare the reduction in IOP of those subjects implanted with two Glaukos
      micro-stents with the reduction in IOP for patients receiving only primary medical therapy
      (Xalatan - Latanoprost) or cataract surgery alone. Both groups will undergo routine cataract
      surgery.
    
  